Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is LURASIDONE HYDROCHLORIDE, with a corresponding US DMF Number 28126.
Remarkably, this DMF maintains an Active status since its submission on April 18, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 01, 2014, and payment made on April 15, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II